1,467 Results
WHO lists first molecular diagnostic for Ebola Bundibugyo virus under EUL, seven weeks after PHEIC declaration over the DRC outbreak.
WHO's PARTNERS trial opens BVD enrolment in DRC, evaluating MBP134 and remdesivir under an adaptive platform design with no approved filovirus treatments.
Aarti Pharmalabs' new Tarapur block lifts xanthine derivatives capacity to 9,600 TPA, placing the company among the world's top three producers.
Rockwell Automation and Cisco launch a software-defined manufacturing framework in India, with direct implications for GMP-aligned IT/OT convergence in pharma plants.
Roche's second India digital hub in Hyderabad, due Q1 2027, expands its global technology network supporting manufacturing and quality operations.
FDA grants Sanofi concurrent annual approval for Fluzone and Fluzone High-Dose, confirming 2026–27 seasonal authorization under STN BL 103914.
FDA approves FluLaval Quadrivalent for 2026–2027 season; lot release and GMP compliance timelines now active for ID Biomedical.